FABP3 and coronary artery disorder: When the glucose metabolism status was incorporated in H-FABP stratification, data revealed that the higher tertile of H-FABP patients were associated with higher risk of CVEs in pre-DM (adjusted HR: 1.855, 95% CIs 1.076–3.214, p = 0.033), suggesting that H-FABP could be an independently index of adverse outcomes in CAD patients with pre-DM.